BIOCOM Medical Device Event

Posted by

Is FDA Stifling Your Innovations? What Can You Do?

With the current challenges in the U.S. regulatory pathway, med tech companies are forced to explore other avenues to bring products to market. Many companies are looking outside of the U.S. for their initial launch.

The panel will discuss the pros and cons of launching a new medical innovation outside of the U.S. What drove the decision? What steps did they take? And what lessons did they learn?


Panel Members:

  • Mike Oliver, President and CEO, SpectraScience
  • Allan Rozenberg, PhD, Chief Operating Officer, Benechill
  • Richard Strobridge, CEO, Entra Health Systems


Event Details:

When: Wednesday, November 30, 2011, 5:00 p.m. – 7:00 p.m.

Where: Hilton La Jolla Torrey Pines, 10950 N. Torrey Pines Rd , La Jolla, California 92037

Cost: $20.00 for BIOCOM members, $35.00 for non-members


Moderator: Noel Gillespie, Partner, Procopio, Cory, Hargreaves & Savitch LLP

Planner: Asleigh Berry

RSVP: Tuesday, November 29, 2011 12:00 p.m.

Sponsor: Procopio


San Diego Cluster Snapshot

The San Diego life science cluster is one of the life science hubs within Southern California. The region hosts roughly 700 companies and 44,000 employees with a focus on medical devices, biotech and diagnostics.